Alkermes Plc (ALKS) - Total Liabilities
Based on the latest financial reports, Alkermes Plc (ALKS) has total liabilities worth $710.96 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Alkermes Plc operating cash flow efficiency to assess how effectively this company generates cash.
Alkermes Plc - Total Liabilities Trend (1991–2025)
This chart illustrates how Alkermes Plc's total liabilities have evolved over time, based on quarterly financial data. Check Alkermes Plc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Alkermes Plc Competitors by Total Liabilities
The table below lists competitors of Alkermes Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Algonquin Power & Utilities Corp
TO:AQN
|
Canada | CA$8.71 Billion |
|
Haci Omer Sabanci Holding AS
IS:SAHOL
|
Turkey | TL3.19 Trillion |
|
Dottikon Es Holding AG
SW:DESN
|
Switzerland | CHF348.89 Million |
|
Wacker Chemie AG
XETRA:WCH
|
Germany | €5.04 Billion |
|
Cochlear Ltd
AU:COH
|
Australia | AU$874.70 Million |
|
Henan Zhongfu Industrial Co Ltd
SHG:600595
|
China | CN¥7.55 Billion |
|
Guangdong Electric Power Development Co Ltd
SHE:000539
|
China | CN¥144.85 Billion |
|
CECEP Wind-Power Corp Co Ltd
SHG:601016
|
China | CN¥26.39 Billion |
Liability Composition Analysis (1991–2025)
This chart breaks down Alkermes Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Alkermes Plc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alkermes Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alkermes Plc (1991–2025)
The table below shows the annual total liabilities of Alkermes Plc from 1991 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $710.96 Million | +20.38% |
| 2024-12-31 | $590.59 Million | -36.74% |
| 2023-12-31 | $933.54 Million | +1.45% |
| 2022-12-31 | $920.23 Million | +0.91% |
| 2021-12-31 | $911.90 Million | +3.30% |
| 2020-12-31 | $882.75 Million | +22.61% |
| 2019-12-31 | $719.96 Million | +10.13% |
| 2018-12-31 | $653.72 Million | +9.98% |
| 2017-12-31 | $594.42 Million | +14.99% |
| 2016-12-31 | $516.94 Million | -4.53% |
| 2015-12-31 | $541.47 Million | +3.25% |
| 2014-12-31 | $524.43 Million | +2.35% |
| 2013-12-31 | $512.40 Million | -1.07% |
| 2012-12-31 | $517.92 Million | -10.91% |
| 2011-12-31 | $581.37 Million | +862.05% |
| 2010-12-31 | $60.43 Million | -41.32% |
| 2009-12-31 | $102.98 Million | +2.29% |
| 2008-12-31 | $100.67 Million | -71.32% |
| 2007-12-31 | $351.00 Million | +1.49% |
| 2006-12-31 | $345.84 Million | -6.82% |
| 2005-12-31 | $371.14 Million | +10.87% |
| 2004-12-31 | $334.76 Million | +82.96% |
| 2003-12-31 | $182.97 Million | -7.52% |
| 2002-12-31 | $197.85 Million | -15.01% |
| 2001-12-31 | $232.78 Million | -12.22% |
| 2000-12-31 | $265.18 Million | +9.47% |
| 1999-12-31 | $242.25 Million | +382.59% |
| 1998-12-31 | $50.20 Million | -6.75% |
| 1997-12-31 | $53.83 Million | +110.72% |
| 1996-12-31 | $25.55 Million | +5.91% |
| 1995-12-31 | $24.12 Million | +55.62% |
| 1994-12-31 | $15.50 Million | +7.64% |
| 1993-12-31 | $14.40 Million | +128.57% |
| 1992-12-31 | $6.30 Million | +320.00% |
| 1991-12-31 | $1.50 Million | -- |
About Alkermes Plc
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and … Read more